Clinical Trial Update: Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma [EARLY_Phase 1]

View source ↗

Summary

Clinical trial update announcing an EARLY Phase 1 study of niraparib for newly diagnosed glioblastoma and recurrent glioma; the trial status is active but not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioma

Drugs mentioned

• Niraparib (Niraparib)

Snippet

Sponsor: Nader Sanai | Conditions: Glioblastoma, Glioblastoma Multiforme | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING